Current Surgical Treatment of Gynecomastia
Main Article Content
Abstract
Gynecomastia is the proper growth in size and proportion of glandular breast tissue in men. It has various etiologies. Regardless of the stimulus or etiology, whether physiological or pathological, histologically the same changes will occur. The most used categorization for patients with gynecomastia is that of Simon BE. The management of each patient must be staggered, individualized and always offering the greatest safety. The surgeon must know this pathology to know all the therapeutic targets and their arsenal for management, surgical treatment must be reserved for selected cases and is an excellent alternative.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Bonilla-Sepúlveda, O. A. (2021). Ginecomastia: aspectos generales y etiológicos. Medicina y Laboratorio, 25(1), 393-408.
II. Pedro Rafael, C. M., Rafael Salvador, S. F., Dania, J. A., Carmen Elena, F. M., Nirza, G. V., & Yisel, S. C. (2020, August). CARACTERIZACIÓN CLÍNICO-BIOQUÍMICA DE LA GINECOMASTIA. In Morfovirtual 2020.
III. Holzmer, S. W., Lewis, P. G., Landau, M. J., & Hill, M. E. (2020). Surgical management of gynecomastia: a comprehensive review of the literature. Plastic and Reconstructive Surgery Global Open, 8(10).
IV. Kanakis, G. A., Nordkap, L., Bang, A. K., Calogero, A. E., Bártfai, G., Corona, G., ... & Jørgensen, N. (2019). EAA clinical practice guidelines—gynecomastia evaluation and management. Andrology, 7(6), 778-793.
V. Baumann, K. (2018). Gynecomastia-conservative and surgical management. Breast care, 13(6), 419-424.
VI. Sollie, M. (2018). Management of gynecomastia—changes in psychological aspects after surgery—a systematic review. Gland surgery, 7(Suppl 1), S70.